A possible H5N1 vaccine A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh’s Middle for Vaccine Study and Novavax Inc. Relating to a report published by the Public Library of Technology in the Jan. 30 issue of PLoS ONE, the vaccine created a strong immune response in mice and protected them from loss of life following illness with the H5N1 virus. The vaccine has been tested in humans within an early-phase clinical trial. Latest outbreaks of avian flu around the world possess prompted wellness officials to warn of its continued threat to global health insurance and potential to trigger a flu pandemic.Attorney for the Central District of California George S. Cardona. Assistant U.S. Attorney Vince Farhat may be the Strike Power coordinator in LA. Since inception in March 2007, Strike Force operations in four districts have resulted in indictments of 331 people who collectively have falsely billed the Medicare system for more than $720 million. Furthermore, HHS’ Centers for Medicare and Medicaid Services, employed in conjunction with the HHS-OIG, are taking guidelines to increase accountability and decrease the presence of fraudulent suppliers..